Changing trends in HPV vaccination in Japan

After the Japanese Ministry of Health, Labor and Welfare (MHLW) suspended its recommendation for the human papillomavirus (HPV) vaccine in June 2013, the rate of members of the new target population receiving of at least one of three doses of HPV vaccine declined, reaching 0.3% in 2016. Recently, ho...

Full description

Bibliographic Details
Main Authors: Mugen Ujiie, Taito Kitano, Shinya Tsuzuki
Format: Article
Language:English
Published: Taylor & Francis Group 2022-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2021.1986333
_version_ 1797673337948733440
author Mugen Ujiie
Taito Kitano
Shinya Tsuzuki
author_facet Mugen Ujiie
Taito Kitano
Shinya Tsuzuki
author_sort Mugen Ujiie
collection DOAJ
description After the Japanese Ministry of Health, Labor and Welfare (MHLW) suspended its recommendation for the human papillomavirus (HPV) vaccine in June 2013, the rate of members of the new target population receiving of at least one of three doses of HPV vaccine declined, reaching 0.3% in 2016. Recently, however, the monthly number of vaccines delivered to healthcare facilities has significantly increased, from 878 doses over December 2016–April 2017 to 35,396 doses over January–March 2021. This may be due to governmental efforts to convey information about the HPV vaccination to the eligible population and their caregivers, as well as local educational programs, despite ongoing suspension of the recommendation. The incidence of reported adverse events per vaccine dose has not increased since 2016. While governmental recommendation of the HPV vaccination remains essential for optimal vaccine coverage, the recent increase in the number of doses delivered to healthcare facilities is promising.
first_indexed 2024-03-11T21:43:07Z
format Article
id doaj.art-d7e515a8ef0942128650b3ae53427e65
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T21:43:07Z
publishDate 2022-01-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-d7e515a8ef0942128650b3ae53427e652023-09-26T12:43:42ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-01-011811310.1080/21645515.2021.19863331986333Changing trends in HPV vaccination in JapanMugen Ujiie0Taito Kitano1Shinya Tsuzuki2Vaccination Support Center, National Center for Global Health and MedicineJohns Hopkins Bloomberg School of Public HealthAMR Clinical Reference Center, National Center for Global Health and MedicineAfter the Japanese Ministry of Health, Labor and Welfare (MHLW) suspended its recommendation for the human papillomavirus (HPV) vaccine in June 2013, the rate of members of the new target population receiving of at least one of three doses of HPV vaccine declined, reaching 0.3% in 2016. Recently, however, the monthly number of vaccines delivered to healthcare facilities has significantly increased, from 878 doses over December 2016–April 2017 to 35,396 doses over January–March 2021. This may be due to governmental efforts to convey information about the HPV vaccination to the eligible population and their caregivers, as well as local educational programs, despite ongoing suspension of the recommendation. The incidence of reported adverse events per vaccine dose has not increased since 2016. While governmental recommendation of the HPV vaccination remains essential for optimal vaccine coverage, the recent increase in the number of doses delivered to healthcare facilities is promising.http://dx.doi.org/10.1080/21645515.2021.1986333human papillomavirusvaccinesurveillanceadverse eventhpv vaccine
spellingShingle Mugen Ujiie
Taito Kitano
Shinya Tsuzuki
Changing trends in HPV vaccination in Japan
Human Vaccines & Immunotherapeutics
human papillomavirus
vaccine
surveillance
adverse event
hpv vaccine
title Changing trends in HPV vaccination in Japan
title_full Changing trends in HPV vaccination in Japan
title_fullStr Changing trends in HPV vaccination in Japan
title_full_unstemmed Changing trends in HPV vaccination in Japan
title_short Changing trends in HPV vaccination in Japan
title_sort changing trends in hpv vaccination in japan
topic human papillomavirus
vaccine
surveillance
adverse event
hpv vaccine
url http://dx.doi.org/10.1080/21645515.2021.1986333
work_keys_str_mv AT mugenujiie changingtrendsinhpvvaccinationinjapan
AT taitokitano changingtrendsinhpvvaccinationinjapan
AT shinyatsuzuki changingtrendsinhpvvaccinationinjapan